Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS)
Bibliographic record
Abstract
Abstract Background and Aims Myelodysplastic syndromes (MDS) present significant diagnostic and therapeutic challenges, often requiring input from multidisciplinary teams and subspecialty-trained leukemia and pathology experts. The complexity is compounded by evolving classification systems (e.g., WHO and ICC) and an expanding therapeutic landscape, which complicate real-time clinical decision-making. Although large language models (LLMs) such as ChatGPT have demonstrated promise in medical domains, they frequently yield inaccurate or overly generalized responses when applied to complex hematologic scenarios. Even state-of-the-art models—capable of human-like reasoning and sometimes outperforming clinicians in general tasks—have not been systematically evaluated in the context of advanced hematologic disorders such as MDS. To address this gap, we first assessed the performance of leading LLMs, including ChatGPT, Claude, and DeepSeek, on challenging, real-world MDS cases. After identifying their limitations, we built the Virtual MDS Panel (VMP), a coordinated AI system in which AI agents—task-bound software assistants that understand natural language and help users complete tasks, answer questions, and make decisions efficiently—are trained on domain knowledge (WHO/ICC; IPSS-R/IPSS-M; NCCN) and explicit decision rules to collaborate and produce tumor-board–level recommendations. Methods VMP comprises four specialized AI agents: a moderator agent that receives clinical queries; a pathology agent trained on WHO/ICC criteria; a prognostication agent using risk models (IPSS, IPSS-R, IPSS-M) and a therapy agent grounded in NCCN and ELN guidelines. For each case, a physician submits a clinical scenario to the moderator, which breaks down the query and delegates sub-tasks to relevant agents. The moderator then synthesizes their responses into a structured output. To evaluate performance, we created a test set of 30 complex, real-world MDS cases. VMP responses were compared to those from leading LLMs (ChatGPT-4o, GPT-o3, Claude, DeepSeek). Eleven international MDS experts, blinded to response sources, independently scored outputs for accuracy, clinical relevance, and completeness (Likert scale 1–5). They also assessed diagnostic reasoning, prognostic validity, and treatment recommendations, while classifying factual errors as none, minor, or major. To evaluate the consistency of expert ratings, we used the intraclass correlation coefficient (ICC) to measure how well experts agreed on numerical scores and Cohen's κ (kappa) to assess their agreement when identifying errors. Results VMP achieved an overall expert-rated accuracy of 93%, outperforming GPT-o3 (82%), GPT-4o (80%), DeepSeek (71%), and Claude (66%). When examining each domain, the VMP overall scored highest 4.2 (mean on scale from 1-5 among all experts): Diagnosis 4.3, Prognosis 4.4 and therapy selection 3.9, compared to GPT-o3, at 3.6 overall, 3.7 / 3.6 / 3.6, GPT-4o (3.2 overall) 3.1 / 3.2 / 3.4, DeepSeek (3.0) 2.9 / 3.0 / 3.1, and Claude (2.9) 2.7 / 2.9 / 3.1, respectively. According to expert opinion, the VMP registered just 9% major factual errors compared to GPT-o3 26%, GPT-4o 26%, DeepSeek 33%, and Claude 36%. Minor factual errors were present at 36% in VMP vs 47-52% in the other 4 models. Experts showed strong agreement in their evaluations, with high consistency in scoring (ICC = 0.81) and in identifying AI errors or hallucinations (κ = 0.76), confirming the reliability of the review process.Conclusions We developed an advanced, MDS-focused AI system that increased accuracy and alignment with expert practice, outperforming current state-of-the-art general AI models. By emulating a virtual tumor board, the system offers structured, evidence-based guidance that can aid hematologists in optimizing their precision care.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.008 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.002 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.006 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".